MAB Discovery GmbH-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:MAB Discovery GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014269
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MAB Discovery GmbH (MAB Discovery) is a drug discovery and development company that offers novel antibody therapeutics. The company produces monoclonal antibodies derived from rabbits and rats. It relies on natural immune response and state of the art B cell cloning techniques for the production of monoclonals with unprecedented epitope coverage and potency. MAB Discovery also undertakes projects from immunization, high throughput screening, assay development, and functional characterization. The company partners with biotech and pharmaceutical companies for the discovery and generation of monoclonal antibodies. MAB Discovery is headquartered in Neuried, Germany.

MAB Discovery GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
MAB Discovery GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
MAB Discovery GmbH, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
MAB Discovery GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
MAB Discovery GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
MAB Discovery GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
MAB Discovery GmbH, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
MAB Discovery Enters into Agreement with BioNTech 10
MAB Discovery Enters into Research Agreement with Synthon for Antibodies 11
MAB Discovery Enters into Research Agreement with BioNTech for Monoclonal Antibody Products 12
MAB Discovery Enters into Research Agreement with Genmab for Therapeutic Antibody Products 13
MAB Discovery Enters Into Research Agreement With Pharma Company 14
MAB Discovery Enters Into Research Agreement With US Biotech Company 15
Licensing Agreements 16
Fusion Antibodies Plans to Enter into Licensing Agreement with MAB Discovery 16
Sanofi Enters into Licensing Agreement with MAB Discovery 17
MAB Discovery GmbH – Key Competitors 18
MAB Discovery GmbH – Key Employees 19
MAB Discovery GmbH – Locations And Subsidiaries 20
Head Office 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
MAB Discovery GmbH, Pharmaceuticals & Healthcare, Key Facts 2
MAB Discovery GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
MAB Discovery GmbH, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
MAB Discovery GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
MAB Discovery GmbH, Deals By Therapy Area, 2011 to YTD 2017 8
MAB Discovery GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
MAB Discovery Enters into Agreement with BioNTech 10
MAB Discovery Enters into Research Agreement with Synthon for Antibodies 11
MAB Discovery Enters into Research Agreement with BioNTech for Monoclonal Antibody Products 12
MAB Discovery Enters into Research Agreement with Genmab for Therapeutic Antibody Products 13
MAB Discovery Enters Into Research Agreement With Pharma Company 14
MAB Discovery Enters Into Research Agreement With US Biotech Company 15
Fusion Antibodies Plans to Enter into Licensing Agreement with MAB Discovery 16
Sanofi Enters into Licensing Agreement with MAB Discovery 17
MAB Discovery GmbH, Key Competitors 18
MAB Discovery GmbH, Key Employees 19

★海外企業調査レポート[MAB Discovery GmbH-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Tyson Fresh Meats Inc:戦略・SWOT・企業財務分析
    Tyson Fresh Meats Inc - Strategy, SWOT and Corporate Finance Report Summary Tyson Fresh Meats Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Thundelarra Ltd (THX):企業の財務・戦略的SWOT分析
    Summary Thundelarra Ltd (Thundelarra) is a mining and mineral exploration company. The company acquires, explores and develops lead, zinc, silver, nickel, graphite, copper, gold and uranium prospects in Western Australia and the Northern Territory. Its projects include Red Bore Copper-Gold Project, …
  • PureCircle Ltd:企業の戦略・SWOT・財務情報
    PureCircle Ltd - Strategy, SWOT and Corporate Finance Report Summary PureCircle Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Compania Espanola de Petroleos SAU:石油・ガス:M&Aディール及び事業提携情報
    Summary Compania Espanola de Petroleos SAU (CEPSA) is an integrated energy company. It explores for, produces, refines, transports, and markets and sells crude oil, petroleum products, and natural gas. The company also generates and sells electricity and thermal power to industrial customers and con …
  • Generali Deutschland AG:企業の戦略・SWOT・財務情報
    Generali Deutschland AG - Strategy, SWOT and Corporate Finance Report Summary Generali Deutschland AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Tasly Pharmaceutical Group Co Ltd (600535):企業の財務・戦略的SWOT分析
    Tasly Pharmaceutical Group Co Ltd (600535) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • ALLETE Inc (ALE):電力:M&Aディール及び事業提携情報
    Summary ALLETE Inc (ALLETE) is an energy company. It has interests in mining facilities; electricity generation, transmission, and distribution assets; and water management businesses. The company generates electricity using coal, natural gas, biomass, hydro, wind, and solar; and procures energy thr …
  • Flex Ltd (FLEX):医療機器:M&Aディール及び事業提携情報
    Summary Flex Ltd (Flex) provides design, engineering, manufacturing, and supply chain services to electronics original equipment manufacturers. The company, through its Sketch-to-Scale concept, provides concept design, prototype creation, intellectual property protection, new product introduction, a …
  • Bulgarian Telecommunications Company (VIVACOM):企業の戦略的SWOT分析
    Bulgarian Telecommunications Company (VIVACOM) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitor …
  • Origin Energy Ltd (ORG):電力:M&Aディール及び事業提携情報
    Summary Origin Energy Ltd (Origin Energy) is an integrated energy company. It generates, supplies and distributes electricity; explores and develops natural gas reserves; and produces and sells gas. The company generates electricity from natural-gas fired, coal-fired, wind, solar, pumped water stora …
  • Inditex SA (ITX):企業の財務・戦略的SWOT分析
    Inditex SA (ITX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Chembond Chemicals Ltd (530871):企業の財務・戦略的SWOT分析
    Chembond Chemicals Ltd (530871) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • China Haisheng Juice Holdings Co Ltd:企業の戦略・SWOT・財務情報
    China Haisheng Juice Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary China Haisheng Juice Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Kyoto University-製薬・医療分野:企業M&A・提携分析
    Summary Kyoto University (Kyoto) is a research university that offers educational services. The university provides multi disciplinary courses to students of Japan including medicine, engineering, law, letters, and science. It offers medical services, and diagnoses and treats various health problems …
  • Nestle Health Science SA:医療機器:M&Aディール及び事業提携情報
    Summary Nestle Health Science SA (Nestle Health), a subsidiary of Nestle SA, is a health science company that manufactures nutritional and medicinal products derived from botanical plants. The company provides nutritional therapies for chronic conditions related to gastrointestinal diseases, aging p …
  • BLS AG:企業の戦略・SWOT・財務情報
    BLS AG - Strategy, SWOT and Corporate Finance Report Summary BLS AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Ezz Steel Company SAE:企業の戦略・SWOT・財務分析
    Ezz Steel Company SAE - Strategy, SWOT and Corporate Finance Report Summary Ezz Steel Company SAE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Bertelsmann SE & Co. KGaA:企業の戦略・SWOT・財務情報
    Bertelsmann SE & Co. KGaA - Strategy, SWOT and Corporate Finance Report Summary Bertelsmann SE & Co. KGaA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • LHC Group Inc (LHCG):企業の財務・戦略的SWOT分析
    Summary LHC Group Inc (LHC Group) is an in-home healthcare service provider. The center offers home health, hospice, personal care services and facility-based services. It covers a range of healthcare needs for patients and families dealing with illness, injury, and chronic conditions. LHC Group pro …
  • Senvion SA:電力:M&Aディール及び事業提携情報
    Summary Senvion S.A. (Senvion) formerly Senvion S.a.r.l, is a renewable energy company that develops, produces and distributes onshore and offshore wind turbines and towers. It also offers project specific solutions such as turnkey, foundation construction, transport and installation, and service an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆